Resultados da busca - Julie‐An Talano

  • Mostrando 1 - 19 resultados de 19
Refinar Resultados
  1. 1
    Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art

    Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art por James A. Connelly, Rebecca Marsh, Suhag Parikh, Julie‐An Talano

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Delayed Hemolytic Transfusion Reaction/Hyperhemolysis Syndrome in Children With Sickle Cell Disease

    Delayed Hemolytic Transfusion Reaction/Hyperhemolysis Syndrome in Children With Sickle Cell Disease por Julie‐An Talano, Cheryl A. Hillery, Jerome L. Gottschall, Diane M. Baylerian, James G. Scott

    Publicado em 2003
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis

    Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis por Larisa Broglie, Lauren Pommert, Sridhar Rao, Monica S. Thakar, Rachel Phelan, David M. Margolis, Julie‐An Talano

    Publicado em 2017
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Association of Crohn’s Disease, Thiopurines, and Primary Epstein-Barr Virus Infection with Hemophagocytic Lymphohistiocytosis

    Association of Crohn’s Disease, Thiopurines, and Primary Epstein-Barr Virus Infection with Hemophagocytic Lymphohistiocytosis por Vincent Biank, Mehul K. Sheth, Julie‐An Talano, David M. Margolis, Pippa Simpson, Subra Kugathasan, Michael C. Stephens

    Publicado em 2011
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study

    Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassion... por Vinod K. Prasad, Kenneth G. Lucas, Gary Kleiner, Julie‐An Talano, David A. Jacobsohn, Gloria Broadwater, Rod Monroy, Joanne Kurtzberg

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Captopril to Mitigate Chronic Renal Failure After Hematopoietic Stem Cell Transplantation: A Randomized Controlled Trial

    Captopril to Mitigate Chronic Renal Failure After Hematopoietic Stem Cell Transplantation: A Randomized Controlled Trial por Eric P. Cohen, Amy A. Irving, William R. Drobyski, John P. Klein, Jakob Passweg, Julie‐An Talano, Mark Juckett, John E. Moulder

    Publicado em 2007
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

    Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients por Joanne Kurtzberg, Susan E. Prockop, Pierre Teira, Henrique Bittencourt, Victor Lewis, Ka Wah Chan, Biljana Horn, Lolie C. Yu, Julie‐An Talano, Eneida R. Nemecek, Charles R. Mills, Sonali Chaudhury

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma

    Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and... por Prakash Satwani, Zhezhen Jin, Paul L. Martin, Monica Bhatia, James H. Garvin, D. George, Sonali Chaudhury, Julie‐An Talano, Erin Morris, Lauren Harrison, Jean Sosna, Margaret Peterson, Olga Militano, S. Foley, Joanne Kurtzberg, Mitchell S. Cairo

    Publicado em 2014
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

    Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders por Lauri M. Burroughs, Akiko Shimamura, Julie‐An Talano, Jennifer Domm, Kelsey K. Baker, Colleen Delaney, Haydar Frangoul, David A. Margolis, K. Scott Baker, Eneida R. Nemecek, Amy E. Geddis, Brenda M. Sandmaier, H. Joachim Deeg, Rainer Storb, Ann E. Woolfrey

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective Multicenter Trial

    Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective Multicenter Trial por Lauri M. Burroughs, Eneida R. Nemecek, Troy R. Torgerson, Barry E. Storer, Julie‐An Talano, Jennifer Domm, Roger Giller, Akiko Shimamura, Colleen Delaney, Suzanne Skoda‐Smith, Monica S. Thakar, K. Scott Baker, David J. Rawlings, Janet A. Englund, Mary E.D. Flowers, H. Joachim Deeg, Rainer Storb, Ann E. Woolfrey

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies

    Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies por Carl E. Allen, Rebecca Marsh, Peter Dawson, Catherine M. Bollard, Shalini Shenoy, Philip Roehrs, Rabi Hanna, Lauri M. Burroughs, Leslie S. Kean, Julie‐An Talano, Kirk R. Schultz, Sung‐Yun Pai, K. Scott Baker, Jeffrey R. Andolina, Elizabeth Stenger, James A. Connelly, Alyssa Ramirez, Christopher Bryant, Mary Eapen, Michael A. Pulsipher

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

    Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience por Beatriz Morillo-Gutiérrez, Rita Beier, Kanchan Rao, Lauri M. Burroughs, Ansgar Schulz, Anna-Maria Ewins, Brenda Gibson, Petr Sedláček, Ladislav Król, Brigitte Strahm, Irina Zaidman, Krzysztof Kałwak, Julie‐An Talano, Ann E. Woolfrey, Chris Fraser, Isabelle Meyts, Ingo Müller, Jacek Wachowiak, Maria Ester Bernardo, Paul Veys, Karl-Walter Sykora, Andrew R. Gennery, Mary Slatter

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial

    Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial por Amy E. DeZern, Mary Eapen, Juan Wu, Julie‐An Talano, Melhem Solh, Blachy J. Dávila Saldaña, Chatchada Karanes, Mitchell E. Horwitz, Kanwaldeep Mallhi, Sally Arai, Nosha Farhadfar, Elizabeth O. Hexner, Peter Westervelt, Joseph H. Antin, H. Joachim Deeg, Eric Leifer, Robert A. Brodsky, Brent R. Logan, Mary M. Horowitz, Richard J. Jones, Michael A. Pulsipher

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

    Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium por Heather E. Stefanski, Anne Eaton, Christina Baggott, Jenna Rossoff, Michael R. Verneris, Snehit Prabhu, Holly Pacenta, Christine L. Phillips, Julie-An Talano, Amy Moskop, Steven Margossian, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, M. Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Vasant Chinnabhandar, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz

    Publicado em 2022
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

    Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy por Vanessa A. Fabrizio, Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie‐An Talano, Amy Moskop, Steven Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vasant Chinnabhandar, Michael Kunicki, A. Yasemin Goksenin, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz, Kevin J. Curran

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

    Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report por Vanessa A. Fabrizio, Christine L. Phillips, Adam Lane, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly Pacenta, Jenna Rossoff, Heather E. Stefanski, Julie‐An Talano, Amy Moskop, Steven Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vasant Chinnabhandar, Michael Kunicki, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

    Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia por Amy Moskop, Lauren Pommert, Christina Baggott, Snehit Prabhu, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Steve P. Margossian, Michael R. Verneris, Gary D. Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Vasant Chinnabhandar, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Erin Guest, Erin H. Breese, Liora M. Schultz

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report

    Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Conso... por Liora M. Schultz, Christina Baggott, Snehit Prabhu, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie‐An Talano, Amy Moskop, Steven Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Rayne H. Rouce, Vasant Chinnabhandar, Michael Kunicki, Valentin Barsan, A. Yasemin Goksenin, Yimei Li, Sharon Mavroukakis, Emily Egeler, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch

    Publicado em 2021
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

    Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Re... por Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori, Rebecca Marsh, Lauri M. Burroughs, Navneet S. Majhail, A. Samer Al‐Homsi, Zaid Al‐Kadhimi, Merav Bar, Alice Bertaina, Jaap Jan Boelens, Richard E. Champlin, Sonali Chaudhury, Zachariah DeFilipp, Bhagirathbhai Dholaria, Areej El‐Jawahri, Suzanne Fanning, Ellen Fraint, Usama Gergis, Sergio Giralt, Betty K. Hamilton, Shahrukh K. Hashmi, Biljana Horn, Yoshihiro Inamoto, David A. Jacobsohn, Tania Jain, Laura Johnston, Abraham S. Kanate, Ankit Kansagra, Adetola A. Kassim, Leslie S. Kean, Carrie L. Kitko, Jessica Knight‐Perry, Joanne Kurtzberg, Hien Liu, Margaret L. MacMillan, Zahra Mahmoudjafari, Marco Mielcarek, Mohamad Mohty, Arnon Nagler, Eneida R. Nemecek, Timothy S. Olson, Betül Oran, Miguel‐Angel Perales, Susan E. Prockop, Michael A. Pulsipher, Iskra Pusic, Marcie L. Riches, Cesar Rodriguez, Rizwan Romee, Gabriela Rondón, Ayman Saad, Nina Shah, Peter J. Shaw, Shalini Shenoy, Jorge Sierra, Julie‐An Talano, Michael R. Verneris, Paul Veys, John E. Wagner, Bipin N. Savani, Mehdi Hamadani, Paul A. Carpenter

    Publicado em 2021
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: